UK MHRA’s IVD Chief Warns About ‘Wrong’ Deviation From EU Medtech Regulations
Executive Summary
Ahead of the MHRA’s release of its post-UK regulatory consultation findings, the agency’s Mike Messenger outlined ongoing thought processes for how regulation should drive efficiencies in diagnostics.